m-Clinical Solutions

m-Clinical uses data and tech to streamline the drug approva...


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9



Clinical trials are becoming increasingly complex and health care costs are spiraling.

It’s difficult to enroll hospital patients in clinical trials, costs are increasing year by year, data accuracy is costing people delay in treatment and, for some, their lives.

As the world waits for a COVID-19 vaccine, how quickly will a feasible and safe option be available?



m-Clinical utilizes big data and technology to fill the gaps in clinical trial methodologies.

Our all-in-one platform seamlessly integrates diverse data, deep learning, AI, and blockchain technology to surface the most valuable insights for pharmaceutical, biotech, government, and academic fields.

By partnering the right stakeholders with intelligent technology solutions, m-Clinical helps streamline the drug approval process, and ultimately bridge the gap between the prediction of disease outbreaks and the creation of life-saving treatments.

Both of our SaaS platforms, professional services, and hosting solutions were created to help researchers speed up the FDA approval process and pinpoint the outbreak of diseases in advance.

Both of our systems provide timely document creation, process management tools, document version, history management, fast and secure access, and more to standardize the information management process of clinical trial documents.

Our diverse team has years of industry experience and the know-how to develop valuable partnerships with drug and research institutions.

JOSEPH NG - FOUNDER, CEO 
25+ years of experience in Life Science Technology. Formerly with Institute of Systems Science, Apple Computer, Richfield, Fast Track and Medidata.

PROF. DANIEL LIU - CO FOUNDER, CSO 
20+ years of experience in global clinical trial management companies. Former experience with Novartis, Pfizer, Sanofi, Schering-Ploug, J&J and Medidata.

DR. MURPHY LIU, MD - CO FOUNDER, CMO
MD in Clinical Oncology, China Medical University. Has 17 years of experience in drug research and development, including medical marketing.

SHYAM VELUMANI - CBDO, GM INDIA
15+ years of experience in sales, marketing and strategy consulting across blue-chip companies such as IBM, Syntel, P&G, GE, Dell.

VIDDYASAGAR CS  - CTO EVP
17+ years of experience in enterprise architecture. Specializes in enterprise applications involving enterprise resource planning, middleware suites, governance risk and compliance.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.